MERCK & CO. INC. (MRK:NYSE)
$119.27 -2.15 (-1.7707%)
Analysed MERCK & CO. INC. (MRK:NYSE) News Sources
This Biotech Stock Soars 38%. Pancreatic Cancer Trial Was a Success.
13-04-2026
yahoo.com
Ifinatamab Deruxtecan Granted Priority Review in the U.S. for Adult Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer who Experienced Disease Progression on or After Platinum-Based Chemotherapy
13-04-2026
yahoo.com
Big Pharma Is Thinking Small on Deals. That’s a Boon for Biotech.
13-04-2026
yahoo.com
Merck Extends KEYTRUDA Reach As New LDL Drug Nears FDA Decision
12-04-2026
yahoo.com
Organon (OGN) Climbs 39% on $12-Billion Merger Buzz
11-04-2026
yahoo.com
This Women’s Health Company Is Drawing Takeover Interest. The Stock Is Soaring.
10-04-2026
yahoo.com
BMY Gains 10% Year to Date: Should You Buy, Sell or Hold the Stock?
10-04-2026
yahoo.com
Radiant Journey LLC Founder Dr. Lori Ana Valentín Brings Forensic Science Background to Leadership Coaching for STEM Professionals
10-04-2026
yahoo.com
Nvidia Who? This Highflier Keeps Popping Onto This Elite Screen
10-04-2026
yahoo.com
Biopharma Stocks Largely Exempt From Pharma Tariffs, BofA Says
09-04-2026
yahoo.com
What is the current price of MERCK & CO. INC. (MRK:NYSE)?
The current price of MERCK & CO. INC. (MRK:NYSE) is $119.27.
MERCK & CO. INC. (MRK:NYSE) absolute price change since previous trading day?
The absolute price change of MERCK & CO. INC. (MRK:NYSE) since the previous trading day is $-2.15.
MERCK & CO. INC. (MRK:NYSE) percentage price change since previous trading day?
The percentage price change of MERCK & CO. INC. (MRK:NYSE) since the previous trading day is -1.7707%.
What is the most recent average sentiment score for MERCK & CO. INC. (MRK:NYSE)?
The most recent average sentiment score for MERCK & CO. INC. (MRK:NYSE) is 76 out of 100.
What is the most recent average sentiment for MERCK & CO. INC. (MRK:NYSE)?
The most recent sentiment for MERCK & CO. INC. (MRK:NYSE) is .
SEC-8K** Filing Available For MERCK & CO. INC. (MRK:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.